Boosting short-term dry eye management in patients
October 12, 2020
Fast-acting efficacious options are key to treating acute inflammation
© 2020 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Dry Eye
Where to start with treating OSD patients
October 17, 2020
Cynthia Matossian, MD, FACS, advises on how ophthalmologists can start performing a better diagnosis of ocular surface disease in three simple steps.
Evaluating and treating tear film patients with success
October 07, 2020
Cynthia Matossian, MD, FACS, explains why she believes if ophthalmologists consistently evaluate the ocular surface, tear film and lid margins—and treat any problems that we find—surgical outcomes will improve.
Examining ocular allergy, quality of life
September 28, 2020
Surveyed patients express dissatisfaction with efficacy of eye drops.
As cyclosporine options grow, focus remains on the vehicle
September 10, 2020
Amid a surge in dry eye cases since reopening her practice during the ongoing pandemic, Lisa Nijm, MD, JD, shares how cyclosporine, a well-established form of treatment, poses both challenges and advantages for ophthalmologists.
Artificial tears offer a path to contact lens comfort
September 04, 2020
Nanodrop technology improves lens comfort
2020 vision: The future of ophthalmology (Part III)
August 29, 2020
Susan Coultas, PhD, and Preeya Gupta, MD, share their hopes for continued innovation in the ophthalmic space — including dry eye and retina — as well as the importance of the clinical research process.
Kala’s dry eye treatment nears potential US launch before 2021
August 25, 2020
Susan Coultas, PhD, and Preeya Gupta, MD, discuss Kala Pharmaceuticals’ dry eye product candidate in a poster presentation during the 2020 Women in Ophthalmology virtual summer symposium.
Making dry eye manageable for patients working from home
August 19, 2020
One ophthalmologist offers insight on how to help patients treat their dry eye symptoms when working from home amid the pandemic.
New molecule for allergic conjunctivitis makes debut
July 10, 2020
First new therapy in nearly a decade offers another option for physicians, patients